Evidence map›Paper›PMID 26315532›Full record

ArticleJournal of the American Society of Nephrology : JASN2016

Double-Negative αβ T Cells Are Early Responders to AKI and Are Found in Human Kidney.

Maria N Martina, Sanjeev Noel, Ankit Saxena, Samatha Bandapalle, Richa Majithia, Chunfa Jie, Lois J Arend, Mohamad E Allaf, Hamid Rabb, Abdel Rahim A Hamad

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. T-cell receptor αβImmunology and cell biology · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Maria N MartinaDepartment of Pathology.
Sanjeev NoelDepartment of Medicine, and.
Ankit SaxenaDepartment of Pathology.
Samatha BandapalleDepartment of Medicine, and.
Richa MajithiaDepartment of Pathology.
Chunfa JieDepartment of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Lois J ArendDepartment of Pathology.
Mohamad E AllafDepartment of Urology, Johns Hopkins University, Baltimore, Maryland, and.
Hamid RabbDepartment of Medicine, and hrabb1@jhmi.edu.
Abdel Rahim A HamadDepartment of Pathology.
Johns Hopkins University · USNorthwestern University · US

Funding

Acute Kidney Injury and Double Negative T CellsR01DK104662 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI HAMAD, ABDEL RAHIM, RABB, HAMID · 2015 to 2023
$3.8M
Mechanisms of Fas Ligand Control of Insulitis in Autoimmune DiabetesR01AI099027 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HAMAD, ABDEL RAHIM · 2013 to 2017
$2.0M
Targeting T lymphocyte Keap1 for acute kidney injuryR01DK111209 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI RABB, HAMID · 2016 to 2019
$1.8M
Acute Kidney Injury and Double Negative T CellsR21AI095484 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HAMAD, ABDEL RAHIM, RABB, HAMID · 2012 to 2013
$446k
NIAID NIH HHS 1R21AI095484-01NIAID NIH HHS R01 AI099027NIAID NIH HHS R21 AI095484NIDDK NIH HHS R01 DK104662NIDDK NIH HHS R01 DK111209
6 · The paper itself

Abstract

Ischemia-reperfusion injury (IRI) is a major cause of AKI, and previous studies established important roles for conventional CD4(+) T cells, natural killer T cells, and CD4(+)CD25(+)FoxP3(+) Tregs in AKI pathogenesis. We recently identified CD4(-)CD8(-) (double-negative; DN) T cells as an important subset of αβ T cell receptor-positive cells residing in mouse kidney. However, little is known about the pathophysiologic functions of kidney DN T cells. In this study, we phenotypically and functionally characterized murine kidney DN T cells in the steady state and in response to IRI. Unlike CD4(+) and CD8(+) T cells, DN T cells in the steady state expressed high levels of CD69, CD28, and CD40L; differentially expressed IL-27 and IL-10 anti-inflammatory cytokines; spontaneously proliferated at a very high rate; and suppressed in vitro proliferation of activated CD4(+) T cells. Within the first 3-24 hours after IRI, kidney DN T cells expanded significantly and upregulated expression of IL-10. In adoptive transfer experiments, DN T cells significantly protected recipients from AKI by an IL-10-dependent mechanism. DN T cells also made up a large fraction of the T cell compartment in human kidneys. Our results indicate that DN T cells are an important subset of the resident αβ(+) T cell population in the mammalian kidney and are early responders to AKI that have anti-inflammatory properties.

Indexed as

Acute Kidney InjuryAnimalsCD4 AntigensCD8 AntigensHumansKidneyMaleMiceMice, Inbred C57BLT-LymphocytesCD4 AntigensCD8 Antigensacute kidney injuryCD4−CD8−double-negative T cellshuman kidneyischemia-reperfusion

Identifiers

PMID26315532
PMCPMC4814175
OpenAlexW2180105003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.